Physician profile
Kuldeep Singh
NPI 1659448041
$2,906.95
in general payments reported to CMS, 2019-2025
12 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $81.17 · 2021: $132 · 2022: $189 · 2023: $1,647 · 2024: $477 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,300 · Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,299.58 |
| Food and Beverage | $928.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,332.20 | 2019-2023 | |
| Ethicon US, LLC | $551.54 | 2020-2025 | Enseal, Enseal X1, Echelon Endopath |
| Davol INC. | $397.23 | 2019-2023 | Phasix Mesh |
| Enterra Medical, INC. | $266.93 | 2024 | |
| Novo Nordisk INC | $163.70 | 2022-2025 | Wegovy |
| Baxter Healthcare | $68.60 | 2022-2023 | Peri-Strips Dry |
| Intra-Sana Laboratories | $27.86 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| C. R. Bard, INC. & Subsidiaries | $27.71 | 2023 | Arista Ah Flexitip |
| Rhythm Pharmaceuticals, INC. | $18.68 | 2022 | |
| Endo Pharmaceuticals INC. | $18.15 | 2023 | Nascobal |
| Lilly USA, LLC | $17.48 | 2024 | Zepbound |
| Millicent US INC | $16.87 | 2023 | Intrarosa, Femring |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kuldeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.